IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma

Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies

Expression and structure of interleukin 4 receptors in primary meningeal tumors

Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas

Cytotoxins directed at interleukin-4 receptors as therapy for human brain tumors.

Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma

Convection-enhanced Delivery of Free Gadolinium with the Experimental Chemotherapeutic Agent PRX321

Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy

In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures

IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein

Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant
glioma therapy

Convection-Enhanced Drug Delivery of Interleukin-4 Pseudomonas Exotoxin (PRX321): Increased Distribution and Magnetic Resonance Monitoring

Toxicologic Pathology of Cytokines, Cytokine Receptors, and Other Recombinant Human Proteins – Development of a Recombinant Interleukin-4-Pseudomonas Exotoxin for Therapy of Glioblastoma

Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein

Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma

A Review of Studies on Targeting Interleukin 4 Receptor for Central Nervous System Malignancy

Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001)

Clinical Studies with Targeted Toxins in Malignant Glioma

Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma

The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin
(NBI-3001) in patients with recurrent malignant glioma

A mathematical model of the impact of infused targeted cytotoxic agents on brain tumours: implications for detection, design and delivery